Labcorp Holdings Inc.
$271.17
▼
-0.82%
2026-04-22 10:12:13
www.labcorp.com
NYQ: LH
Explore Labcorp Holdings Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$22.36 B
Current Price
$271.17
52W High / Low
$293.72 / $209.38
Stock P/E
25.93
Book Value
$104.86
Dividend Yield
1.07%
ROCE
9.74%
ROE
10.51%
Face Value
—
EPS
$10.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
61,770
Beta
0.98
Debt / Equity
75.56
Current Ratio
1.42
Quick Ratio
1.23
Forward P/E
13.53
Price / Sales
1.55
Enterprise Value
$27.51 B
EV / EBITDA
12.55
EV / Revenue
1.97
Rating
Buy
Target Price
$309.47
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
| 2. | Inotiv, Inc. | $0.29 | — | $9.46 M | — | -17.26% | -49.76% | $3.32 / $0.22 | $3.17 |
| 3. | Guardant Health, Inc. | $90.8 | — | $11.97 B | — | -25.56% | 348.42% | $120.74 / $36.36 | $-0.76 |
| 4. | Mainz Biomed N.V. | $0.47 | — | $5.89 M | — | -252.7% | -4.88% | $4.43 / $0.4 | $0.62 |
| 5. | Twist Bioscience Corporation | $61.88 | — | $3.79 B | — | -24.75% | -16.79% | $62.09 / $23.3 | $7.44 |
| 6. | OPKO Health, Inc. | $1.22 | — | $926.06 M | — | -12.27% | -17.14% | $1.6 / $1.09 | $1.67 |
| 7. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 3.52 B | 3.56 B | 3.53 B | 3.35 B | 3.33 B | — |
| Operating Profit | 382 M | 403.2 M | 398.6 M | 332.4 M | 230.7 M | — |
| Net Profit | 164.7 M | 261.1 M | 237.9 M | 212.8 M | 143.4 M | — |
| EPS in Rs | 2 | 3.17 | 2.89 | 2.58 | 1.74 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 13.95 B | 13.01 B | 12.16 B | 11.86 B |
| Operating Profit | 1.52 B | 1.14 B | 1.12 B | 1.75 B |
| Net Profit | 876.5 M | 746 M | 418 M | 1.28 B |
| EPS in Rs | 10.64 | 9.05 | 5.07 | 15.52 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 18.39 B | 18.38 B | 16.73 B | 20.16 B |
| Total Liabilities | 9.76 B | 10.31 B | 8.83 B | 10.04 B |
| Equity | 8.62 B | 8.05 B | 7.88 B | 10.1 B |
| Current Assets | 4.02 B | 4.81 B | 3.77 B | 4.62 B |
| Current Liabilities | 2.82 B | 3.33 B | 3.23 B | 3.08 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.64 B | 1.59 B | 1.33 B | 1.96 B |
| Investing CF | -1.19 B | -1.37 B | -1.17 B | -1.65 B |
| Financing CF | -1.46 B | 779.9 M | -59.3 M | -1.32 B |
| Free CF | 1.21 B | 1.1 B | 874.1 M | 1.53 B |
| Capex | -434.5 M | -489.9 M | -453.6 M | -429.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 7.25% | 6.97% | 2.51% | — |
| Earnings Growth % | 17.49% | 78.47% | -67.32% | — |
| Profit Margin % | 6.28% | 5.73% | 3.44% | 10.78% |
| Operating Margin % | 10.87% | 8.75% | 9.24% | 14.77% |
| Gross Margin % | 28.76% | 27.86% | 27.67% | 31.26% |
| EBITDA Margin % | 14.43% | 13.92% | 11.07% | 16.47% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-27 | $0.72 |
| 2025-11-26 | $0.72 |
| 2025-08-28 | $0.72 |
| 2025-05-29 | $0.72 |
| 2025-02-27 | $0.72 |
Stock Splits
| Date | Split |
|---|---|
| 2023-07-03 | 1:1.164 |